Ahran D. Arnold is an Academic Clinical Lecturer in Cardiovascular Sciences at the National Heart and Lung Institute (NHLI), Imperial College London and a Specialist Registrar in Cardiac Electrophysiology, Complex Devices and Inherited Arrhythmia Syndromes at Hammersmith Hospital, Imperial College Healthcare NHS Trust. He completed his undergraduate medical training at Imperial College London in 2010 with an intercalated BSc in Neuroscience and Mental Health in 2008. He undertook his post-registration general medical training from 2011–2014 in London (Chelsea and Westminster Hospital, Royal Brompton Hospital, King’s College Hospital) in General, Acute, Emergency and Intensive Care medicine, as well as Cardiology and Neurology, at tertiary and quaternary centers. He completed his general cardiology training from 2014–2016 at Royal Brompton Hospital and predominately at Hammersmith Hospital, Imperial College Healthcare NHS Trust alongside research training as an NIHR Academic Clinical Fellow in Cardiology at Imperial College London. He completed an MSc in Health Economics, Outcomes and Management at the London School of Economics in association with the European Heart Academy in 2017. He completed a Ph.D. in 2020 at the NHLI. He was appointed an Academic Clinical Lecturer and Post-Doctoral Research Fellow at NHLI in 2020 alongside completing his sub-specialty training in Complex Devices, Invasive Electrophysiology and Inherited Cardiac Conditions at Hammersmith Hospital.
Zachary I. Whinnett is a Consultant Cardiologist practicing at Imperial College NHS Trust, working principally at Hammersmith and St Mary’s Hospitals. His specialist areas of expertise are pacemakers, implantable defibrillators and cardiac electrophysiology. His main research interests are in the field of cardiac resynchronization therapy. His clinical research program focuses on developing precise and reliable measurement tools to aid in the understanding of the mechanisms through which cardiac resynchronization therapy provides its beneficial effects. This also allows for the identification of areas where this treatment can be improved and allows innovations in the delivery of this treatment to be reliably and efficiently tested.
